Office of Medical Education

Return to Publications

2010

Albuquerque, R.J.C. and Ambati, J., 2010, “Avascularity of the cornea,” Encyclopedia of the Eye, Elsevier Ltd., (Ch. 155), (Book Chapter, In Press).

Pavlakovic, H., Jürgen, B., Albuquerque, R.J.C., Wilting, J., and Ambati, J., 2010, “Soluble VEGFR-2: an anti-lymphangiogenic variant of VEGF receptors,” Ann. N.Y. Acad. Sci., (In press).

Albuquerque, R.J.C., Cho, W., Dridi, S., Kaneko, H., Kleinman, M. , Baffi, J., and Ambati, J., 2010, “Endogenous VEGF-C specifically promotes lymphangiogenesis in the cornea,” Invest. Ophthalmol. Vis. Sci., (mtg. abstract).

McConnell, M.J., Baffi, J.Z., Kaneko, H., Pate, J.C., Kleinman, M.E., Dridi, S., Albuquerque, R.J.C., Pearson, P., and Ambati, J., 2010, “CCR3 as a candidate target for presumed ocular histoplasmosis syndrome diagnosis and therapy,” Invest. Ophthalmol. Vis. Sci., (mtg. abstract).

Kaneko, H., Cho, W., Dridi, S., Baffi, J.Z., Kleinman, M.E., Albuquerque, R.J.C., and Ambati, J., 2010, “RPE of aged mice displays TLR3 activation and dsRNA binding protein reduction. Invest. Ophthalmol. Vis. Sci., (mtg. abstract).

Dridi, S., Kaneko, H., Kleinman, M., Albuquerque, R.J.C., Baffi, J., and Ambati, J., 2010, “Potential role of mitogen-activated protein kinase phosphatase 1 in AMD,” Invest. Ophthalmol. Vis. Sci., (mtg. abstract).

Baffi, J.Z., Kaneko, H., Albuquerque, R.J.C., Blandford, A.D., Green, M.G., Dridi, S., Cho, W.G., McConnell, M.J., Kleinman, M.E., and Ambati, J., 2010, “Inhibition of soluble vascular endothelial growth factor 2: a model for pathogenic lymphangiogenesis in the eye,” Invest. Ophthalmol. Vis. Sci., (mtg. abstract).

Albuquerque, R.J.C. and Ambati, J., 2010, “Soluble VEGFR-2 function and expression is conserved in mammals,” Gordon Research Conference on Molecular Mechanisms In Lymphatic Function & Disease, (mtg. abstract).

Butler, J.E., Fleishaker, E., and Spear, B.T., 2010, “Identification and functional analysis of mouse ornithine aminotrasferase enhancers using bioinformatics and transgenic mice,” (In prep.).

Butler, J.E., Glenn, M., and Spear, B.T., 2010, “Beta-catenin and repression of alpha-fetoprotein enhancer activity in the perinatal liver,” (In prep.).

Chang, A., 2010, “The HMPV F protein H435 region is an important but not sole regulator of fusion triggering,” Negative Strand Virus Meeting Structure and Function Section, (mtg. abstract).

Kleinman, M.E., Cho, W., Fowler, B., Kaneko, H., Dridi, S., Baffi, J.Z., and Ambati, J., 2010, “Molecular mapping of toll-like receptor-mediated retinal pigment epithelial cell responses with functional genomics,” Association for Research in Vision and Ophthalmology: 491/A55, (mtg. abstract).

Kiper, C.E., Schroder, E.A., Van Zant, G., and Satin, J., 2010, “ Cardiac Growth is strain-specific in C57BL/6 and DBA/2 mice,” (In prep.). 

Lefta, M. and Esser, K.A., 2010, “Contribution of the circadian clock gene, Bmal1, in the development of dilated cardiomyopathy,” American Physiology Society, (mtg. abstract).

Meyer, J., Cai, L., Ji, A., Wang, Z., and van der Westhuyzen, D., 2010, “Lipoprotein cholesterol uptake in bone marrow-derived murine macrophages,” FASEB J., 24:664.1, (mtg. abstract).

Silva, S.R., Bowen, K.A., Rychahou, P.G., Jackson, L.N., Lee, E.Y., Townsend, C.M. Jr., and Evers, B.M., 2010, “The role of VEGFR-2 in carcinoid tumor growth and metastatis,” Gastroenterology, 138S1:S-113, (mtg. abstract).

Stephens, D., Kamenini, S., Deane, A., and Printz, M., 2010, “Reconsidering the distal attachments of triceps brachii: Implications for biomechanical function and surgical approach,” (In prep.).

Stephens, D., Pearson, K., Wilkerson, C., and Tenlep, S., 2010, “Long-term returns on a short-term investment: Effects of maternal exercise on glucose tolerance and obesity in BLK6 mice progen,” (In prep.).

Stephens, M.L., Pomerleau, F., Huettl, P., and Gerhardt, G.A., 2010, “Age-associated Changes in Hippocampal Glutamate Regulation Significantly Correlate With Status Epilepticus Behavior and Spontaneous Neurotransmission,” (In prep.).

2009

Kleinman, M.E., Cho, W., Baffi, J.Z., Albuquerque, R.J.C., Nozaki, M., Kaneko, H., Saito, K., Rich, M.G., Rothenberg, M.E., and Ambati, J., 2009 ”Pro-vascular mechanisms and in vivo imaging strategies of CCR3, a specific biomarker for neovascular AMD,” Invest. Ophthalmol. Vis. Sci., 50: E-Abstract 4303, (mtg. abstract).

Rich, M.G., Kleinman, M.E., Kaneko, H., Albuquerque, R.J.C., Saito, K., Cho, W., Baffi, J.Z., and Ambati, J., 2009, “Retinotoxicity as a result Of siRNA activation of toll-like receptor-3,” Invest. Ophthalmol. Vis. Sci., 50: E-Abstract 6155, (mtg. abstract).

Albuquerque, R.J.C., Cho, W., Kleinman, M.E., Kaneko, H.,Rich, M.G., Saito, K., Baffi, J.Z., and Ambati, J., 2009, “Inhibition of lymphangiogenesis by an endogenous soluble VEGF-C receptor,” Invest. Ophthalmol. Vis. Sci., 50: E-Abstract 1965, (mtg. abstract).

Kaneko, H., Kleinman, M.E., Cho, W., Baffi, J.Z., Saito, K., Rich, M.G., Albuquerque, R.J.C., and Ambati, J., 2009, “TLR3 inhibitors blocks double stranded RNA-induced retinal degeneration,” Invest. Ophthalmol. Vis. Sci., 50: E-Abstract 3519, (mtg. abstract).

Saito, K., Kleinman, M.E., Kaneko, H., Yamada, K., Albuquerque, R.J.C., Baffi, J.Z., Cho, W., Rich, M.G., and Ambati, J., 2009,”Sequence-independent suppression of choroidal neovascularization by siRNA Is mediated via thrombospondins,” Invest. Ophthalmol. Vis. Sci., 50: E-Abstract 1162, (mtg. abstract).

Cho, W.G., Kleinman, M.E., Albuquergue, R.J.C., Baffi, J.Z., Kaneko, H., Saito, K., Rich, M.G., and Ambati, J., 2009, “Activation of TLR3 by 21nt-siRNA and intracellular trafficking of the human toll-like receptor 3 upon 21nt-siRNA stimulation,” Invest. Ophthalmol. Vis. Sci., 50: E-Abstract 1189, (mtg. abstract).

Albuquergue, R.J.C., 2009, “sVEGFR-2: a novel endogenous inhibitor of corneal lymphangiogenesis and allograft rejection,” AUPO RPB Forum, (mtg. abstract).

Butler, J.E., Moore, M., Presnell, S.R., Chan, H.-W., Chalupny, N.J., and Lutz, C.T., 2009, “Proteasome Regulation of ULBP1 Transcription,” Keystone Symposia on Molecular and Cellular Biology, Mobilizing Cellular Immunity for Cancer Therapy (A3), (mtg. abstract).

Chang, A., 2009, “Role of Endocytosis on Human Metapneumovirus Entry,” American Society for Virology, (mtg. abstract).

Chang, A., 2009, “Role of endocytosis on human metapneumovirus entry,” Experimental Biology/ASBMB, (mtg. abstract).

Fulkerson, Z.B., Sunkara, M., Drennan, T., Vander Kooi, C., Morris, A.J., and Smyth, S.S., 2009, “Generation of distinct molecular species of the bioactive lipid mediator LPA by autotaxin through interaction with platelet integrins,” ATVB, 29:e14, (mtg. abstract).

Fulkerson, Z.B., 2009, “Interaction of the lysospholipase D autotaxin with integrins,” FASEB conference on Lysolipid Mediators in Health and Disease, (mtg. abstract).

Fulkerson, Z.B., 2009, “Disease Generation of LPA by interaction of the lysospholipase D autotaxin with platelet integrins,” SE Regional Lipid Conference, (mtg. abstract).

Latimer, C.S., Popovic, J., Searcy, J.L., Kadish, I., Thibault, O., and Porter, N.M., 2009, “The Effects of Exercise on Age-Related Changes in Cerebrovasculature and Myelin Integrity,” Society for Neuroscience, (mtg. abstract).

Lefta, M., 2009, “Contribution of the circadian clock gene, Bmal1, in the development of dilated cardiomyopathy,” Chronobiology Congress of the European Biological Rhythms Society (EBRS), (mtg. abstract).

Hatfield, M., Meyer, J., Robles-Carillo, L., Amirkhosravi, A., Meyer, T., and Francis, J., 2009, “Platelet Surface Binding Enhances Immune Complex-Induced Platelet Aggregation,” XXII ISTH Congress, PP-MO-004, (mtg. abstract).

Salous, A., 2009, “Lipid phosphate phosphatases in vascular development and integrity,” SE Regional Lipid Conference, (mtg. abstract).

Salous, A.K., Jones, V., Melguizo Castro, M., Al-Alem, L., and Omar, H.A., 2009, “Adolescent Hormonal Contraception is not Associated with Weight Gain,” ASCI/AAP Joint Meeting, (mtg. abstract).

Salous, A.K., Panchatcharam, M., Miriyala, M., Smyth, S.S., Escalante-Alcade, D., and Morris, A.J, 2009, “Characterization of Mice with Targeted Inactivation of Mouse Lipid Phosphate Phosphatase 3 (mLPP3) in Vascular Endothelium,”  FASEB Summer Research Conference on Lysophospholipid Mediators in Health and Disease, (mtg, abstract).

Bowen, K.A., Silva, S.R., Riall, T.S., Doan, H.Q., and Evers, B.M., 2009, “Population-based analysis and growth factor receptor expression of GI carcinoid tumors,” Gastroenterology, 136S:A-880, (mtg. abstract).

Silva, S.R., Jackson, L.N., Rychahou, P.G., Townsend, C.M. Jr., and Evers, B.M., 2009, “Novel expression and activation of the vascular endothelial growth factor receptor-2 in human carcinoid cells,” Gastroenterology, 136S1:A-759-60, (mtg. abstract).

Jackson, L.N., Chen, L.A., Larson, S.D., Silva, S.R., Rychahou, P.G., Boor, P.J., Li, J., DeFreitas, G., Stafford, W.L., Townsend, C.M. Jr., and Evers, B.M., 2009, “Development and characterization of a novel in vivo model for carcinoid syndrome,” J. Surg. Res., 151:255, (mtg. abstract).

Silva, S.R., Rychahou, P.G., Jackson, L.N., Townsend, C.M. Jr., and Evers, B.M., 2009, “PI3K/AKT signaling affects the expression of VEGF receptor on the carcinoid cell line bon,” J. Surg. Res., 151:199, (mtg. abstract).

Stephens, M.L., Quintero, J.E., Zhang, Z., Huettl, P., Pomerleau, F., Spencer, D.D., Cavus, I., Putz, D., Berger, T., and Gerhardt, G.A., 2009, “Development of Intraoperative Diagnostics for Epilepsy Surgery,”AAP/ASCI, (mtg. abstract).

Huettl, P., Hascup, E., Hascup, K., Pomerleau, F., Stephens, M.L., and Gerhardt, G.A., 2009, “Tools to understanding resting neurotransmitter levels in rats and mice. An awake in vivo state of mind is what matters,” BR, (mtg. abstract).

2008

Nozaki, M., Albuquerque, R.J.C., Kleinman, M.E., De Falco, S., Wilgus, T.A., DiPietro, L.A., and Ambati, J., 2008, “Non-targeted siRNA suppress angiogenesis in the cornea, dermis and hind limb,” Invest. Ophthalmol. Vis. Sci., 49: E-Abstract 525, (mtg. abstract).

Kleinman, M.E., Yamada, K., Takeda, A., Nozaki, M., Albuquerque, R.J.C., Smith, J., Taylor, E.W., and Ambati, J., 2008, “Targeted and non-targeted small interfering RNAs equally suppress choroidal neovascularization through activation of toll-like receptor 3,” Invest. Ophthalmol. Vis. Sci., 49: E-Abstract 3298, (mtg. abstract).

Albuquerque, R.J.C., Hayashi, T., Usui, T., Takeda, A., Kleinman, M.E., Mizuki, N., Peterson, M.L., Yamagami, S., Ambati, B., and Ambati, J., 2008, “Aa21127: a novel endogenous inhibitor of corneal lymphangiogenesis and allograft rejection,” Invest. Ophthalmol. Vis. Sci., 49: E-Abstract 3300, (mtg. abstract).

Butler, J.E., Moore, M., Presnell, S.R., Chan, H,-W., Chalupny, N.J., and Lutz, C,T., 2008, “Proteasome Regulation of ULBP1 Transcription,” Markey Cancer Center, (mtg. abstract).

Butler, J.E., Glenn, M., and Spear, B., 2008, “Pericentral regulation of mouse alpha-fetoprotein enhancer E3 in the adult liver involves beta-catenin signaling and nuclear receptors,” Development and Disease FASEB Research Conference, (mtg. abstract).

Butler, J.E., Moore, M., Presnell, S.R., Chan, H.-W., Chalupny, N.J., and Lutz, C.T., 2008, “Proteasome regulation of stress-activated ligand, ULBP1, in airway squamous cell carcinomas,” 5th Annual KLCR Program Scientists' Seminar, (mtg. abstract).

Kleinman, M.E., Cho, W., Fowler, B., Kaneko, H., Dridi, S., Baffi, J.Z., and Ambati, J., 2010, “Molecular Mapping of Toll-Like Receptor Mediated Retinal Pigment Epithelial Cell Responses With Functional Genomics,” Association for Research in Vision and Ophthalmology, 491:A55, (mtg. abstract).

Grear, K.E. and Estus, S., 2008, “Uncoupling protein-2 and the genetics of T2DM,” Keystone Symposia Conference, (mtg. abstract).

Silva, S.R., Chen, L.A., Doan, H.Q., Townsend, C.M. Jr., and Evers, B.M., 2008, “The carcinoid cell line bon secretes factors that increase proliferation of human colonic and cardiac fibroblasts,” Gastroenterology, 134S1:A-296, (mtg. abstract).

Chen, L.A., Li, J. Silva, S.R., Jackson, L.N., Watanabe, H., Ives, K.L., Hellmich, M.R., and Evers, B.M., 2008, “PKD3 is the predominant PKD isoform expressed in the exocrine pancreas and regulates hormone-induced exocrine enzyme secretion,” Gastroenterology, 134S1:A-127, (mtg. abstract).

Stephens, M.L., Quintero, J.E., Zhang, Z., Huettl, P., Pomerleau, F., Spencer, D.D., Cavus, I., Putz, D., Berger, T., and Gerhardt, G.A., 2008, “Development of Intraoperative Diagnostics for Epilepsy Surgery,” In Viva Methods, MMNS, (mtg. abstract).

Gerhardt, G.A., Pomerleau, F., Huettl, P., Hascup, E., Hascup, K., Quintero, J.E., Stephens, M.L., Talauliker, P.M., and Burmeister, J.J., 2008, “Real-time (2 Hz) measurements of neurotransmission in vivo using enzyme-based microelectrode arrays,” In Vivo Methods, MMNS, (mtg. abstract).

Stephens, M.L., Quintero, J.E., Pomerleau, F., Huettl, P., and Gerhardt, G.A., 2008, “Subregional Comparisons of Real-time Glutamate Neurotransmission in the Rat Hippocampus During Aging,” AAP/ASCI, (mtg. abstract).

2007

Kleinman, M.E., Raisler, B.J., Takeda, A., Albuquerque, R.J.C., Nozaki, M., Baffi, J., Hauswirth, W.W., and Ambati, J., 2007, “Prevention and reversal of drusen-like phenotype in a mouse model of AMD," Invest. Ophthalmol. Vis. Sci., 48: E-Abstract 2354, (mtg. abstract).

Takeda, A., Yamada, K., Nozaki, M., Raisler, B., Albuquerque, R.J.C., Baffi, J., Kleinman, M., Ambati, B., and Ambati, J., 2007, “Soluble VEGF receptor-1 restores corneal avascularity in Corn1 and Pax6+/- mice,” Invest. Ophthalmol. Vis. Sci., 48: E-Abstract 1733, (mtg. abstract).

Albuquerque, R., Nozaki, M., Takeda, A., Kleinman, M., Newcomb, M., Raisler, B., Baffi, J., Ambati, B., and Ambati, J., 2007, “Topical gene ablation of sflt-1 abolishes corneal avascularity,” Invest. Ophthalmol. Vis. Sci., 48: E-Abstract 4454, (mtg. abstract).

Albuquerque, R., Raisler, B., Nozaki, M., Baffi, J.Z., Takeda, A., Collinson, J.M., Leiper, L.J., Ikeda, S., Ambati, B.K., and Ambati, J. 2007, “corneal avascularity is due to soluble VEGF receptor-1,” Invest. Ophthalmol. Vis. Sci. 47: E-Abstract 1628, (mtg. abstract).

Jackson, L.N., Larson, S.D., Silva, S.R., Rychahou, P.G., Chen, L., and Evers, B.M., 2007, “Targeted knockdown of PI3K components with small interfering RNA (SIRNA) inhibits liver regeneration following partial hepatectomy,” J. Surg. Res., 137:153, (mtg. abstract).

2006

Rychahou, P.G., Jackson, L.N., Silva, S.R., Rajaraman, S., and Evers, B.M., 2006, “Targeted molecular therapy of the PI3K pathway: therapeutic significance of PI3K subunit targeting in colorectal carcinoma,” Ann. Surg., 243:833-44, PMID: 16772787, PMCID: PMC1570577, (mtg. abstract).

Jackson, L.N., Larson, S.D., Silva, S.R., Ueda, J., Chen, L.A., and Evers, B.M., 2006, “PI3K/AKT activation is critical for hepatic regeneration after partial hepatectomy,” J. Am. Coll. Surg., 203S1: S11, (mtg. abstract).

Jackson, L.N., Rychahou, P.G., Silva, S.R., and Evers, B.M., 2006, “Differential effects of selective or complete PI3K inhibition in a murine inflammatory bowel disease model,” Gastroenterology, 130S2:A-345, (mtg. abstract).

Jackson, L.N., Silva, S.R., Ueda, J., Watanabe, H., and Evers, B.M., 2006, “PI3K/AKT activation is critical for hepatic regeneration after partial hepatectomy,” J. Surg. Res., 130:301, (mtg. abstract).

Top of Page